Correction
Accepted on 28 Apr 2025
Corrigendum: Development and Validation of Nomogram Models for Predicting Immune-Related Adverse Events in Recurrent and Metastatic Nasopharyngeal Carcinoma Patients Treated with PD-L1 Inhibitors
in Head and Neck Cancer